Rachel D. Dreher

Rachel D. Dreher's research focuses on the molecular biology of Ewing sarcoma, a type of cancer that primarily affects bone and soft tissue in children and young adults. Her recent work centers on a protein called LSD1 (lysine-specific demethylase 1), examining how it regulates gene activity in cancer cells through mechanisms beyond its typical enzymatic function, and how these roles depend on cellular context. This work connects to broader interests in epigenetics (chemical modifications that control gene expression) and gene regulation in cancer.

Publication output was minimal to absent for most of the past decade, with a marked increase starting in 2025 and a large concentration of outputs in 2026, largely tied to a single major study and its associated supplementary materials.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026